MedTrace Logo

SBRT or TACE for Advanced HCC

NCT03338647 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2021-12-02

No results posted yet for this study

Summary

Randomized study of stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) in locally advanced hepatocellular carcinoma.

Conditions

Interventions

DRUG

DEB

Infusion of DEB or doxorubin/lipiodol through catheter in the hepatic artery

RADIATION

SBRT

High precision radiation therapy to the liver tumor(s)

Sponsors & Collaborators

  • International Atomic Energy Agency

    collaborator OTHER_GOV

  • University of Aarhus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-26
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03338647 on ClinicalTrials.gov